MORE►
Paris Hilton
Image: dobackflip.com and AlenaMozhjer/iStock
Follow the Money: Backflip Lands $35M Funding Package, TPG’s Impact Arm Is Raising New Fund, Mark Cuban Makes Two Investments, and More
by Kevin Cummings | May 6, 2022
What companies are finding funding or having a big exit? From startup investments to grants and acquisitions, Dallas Innovates tracks what’s happening in North Texas money.
by Quincy Preston and David Seeley |
Mar 9, 2022
Colossal launched last September with a plan to "de-extinct" the woolly mammoth by using CRISPR genetic engineering to create a mammoth-elephant hybrid.
With a total raise of $75 million to date, the startup aims to
have its first set of mammoth-elephant hybrid calves "in 4 to 6 years," co-founder and CEO Ben Lamm told us. But Colossal's goals extend much further—with the potential "to advance human health, enhance food production, reduce environmental impact, and optimize animal health and welfare."
MORE►
